(Q63831498)
Statements
ACCLAIM (English)
0 references
A Phase II, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Abatacept in Adults With Relapsing-remitting Multiple Sclerosis (English)
0 references
September 2010
0 references
June 2014
0 references
65
0 references
18 year
0 references
65 year
0 references